Neogen/NEOG

$12.16

1.24%
-
1D1W1MYTD1YMAX

About Neogen

Neogen Corporation is engaged in developing, manufacturing and marketing a range of products and services dedicated to food and animal safety. The Company operates through two segments: Food Safety and Animal Safety. Its Food Safety segment consists primarily of diagnostic test kits and complementary products sold to food producers and processors to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues and general sanitation concerns. Its Animal Safety segment is engaged in the development, manufacture, marketing, and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services for the worldwide animal safety market.

Ticker

NEOG

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology & Drugs

CEO

John Adent

Employees

2,640

Headquarters

Lansing, United States

Neogen Metrics

BasicAdvanced
$2.6B
Market cap
1665.74
P/E ratio
$0.01
EPS
1.17
Beta
-
Dividend rate
$2.6B
1.17481
$24.10
$11.95
2.08M
3.817
2.661
28.214
28.294
640.676
1.4%
0.03%
0.05%
0.04%
1,665.742
2.8
0.827
28.93%
-76.99%
25.29%

What the Analysts think about Neogen

Analyst Ratings

Majority rating from 2 analysts.
Buy

Price Targets

Average projection from 1 analyst.
39.8% upside
High $17.00
Low $17.00
$12.16
Current price
$17.00
Average price target

Neogen Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-0.87% profit margin
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$228.8M
-0.35%
Net income
$-2M
-41.18%
Profit margin
-0.87%
-41.22%

Neogen Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 14.29%
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$0.14
$0.11
$0.11
$0.12
-
Expected
-$0.04
$0.13
$0.14
$0.14
$0.11
Surprise
-500%
-12%
-21.43%
-14.29%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Neogen stock?

Neogen (NEOG) has a market cap of $2.6B as of April 17, 2024.

What is the P/E ratio for Neogen stock?

The price to earnings (P/E) ratio for Neogen (NEOG) stock is 1665.74 as of April 17, 2024.

Does Neogen stock pay dividends?

No, Neogen (NEOG) stock does not pay dividends to its shareholders as of April 17, 2024.

When is the next Neogen dividend payment date?

Neogen (NEOG) stock does not pay dividends to its shareholders.

What is the beta indicator for Neogen?

Neogen (NEOG) has a beta rating of 1.17. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

What is the Neogen stock price target?

The target price for Neogen (NEOG) stock is $17, which is 39.8% above the current price of $12.16. This is an average based on projections from 1 analyst, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Neogen stock

Buy or sell Neogen stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing